NDC 0517-4300 – Paclitaxel Protein Bound Particles Albumin Bound
Paclitaxel 100 mg/20mL · Injection, Powder, Lyophilized, For Suspension · Intravenous
Product NDC0517-4300
Product details
- Brand name
- Paclitaxel Protein Bound Particles Albumin Bound
- Generic name
- Paclitaxel
- Labeler
- American Regent, Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Suspension
- Route
- Intravenous
- Marketing category
- NDA · NDA211875
- Marketed since
- May 2, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Microtubule Inhibitor
Active ingredients
- Paclitaxel 100 mg/20mL
Uses, dosage, side effects and warnings for Paclitaxel Protein Bound Particles Albumin Bound →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0517-4300-01 | 1 VIAL in 1 CARTON (0517-4300-01) / 20 mL in 1 VIAL | May 2, 2023 |